Capital Group Growth ETF receives a reiterated 'Hold' rating due to its persistently below-average quality metrics but superior diversification features compared to most passive peers. The fund's lower tech exposure has contributed to inferior returns since its February 2022 inception, but profitability pressures in the sector could lead to it being a tailwind. CGGR has a lower ROE "premium" than peers like GARP, QQQ, SCHG, VOOG, IVW, VUG, IWY, VONG, and ILCG, indicating its ~20% next-year EPS growth rate could hold up better.
Capital Group Growth ETF is downgraded to Hold due to its balanced portfolio and lower tech exposure, limiting upside in 2026. CGGR underperformed peers year-to-date, returning 3.5% versus QQQM's 18% and FBCG's 12%, reflecting weaker sector allocation. CGGR's higher weights in healthcare and financials, plus underweighting mega-cap tech, may hinder returns despite strong liquidity and AUM.
Capital Group Growth ETF and Invesco QQQ Trust both serve as aggressive growth equity holdings but differ in management style and sector exposure. CGGR is actively managed with a lower tech allocation (~33%) and more international/mid-cap exposure, while QQQ is passive, tech-heavy (~54%), and large-cap focused. My investing bias is toward hyperscalers and tech stocks currently, favoring QQQ's more concentrated sector positions over CGGR's diversity, but both funds have a high correlation and similar beta.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 220,603 | $8.13M | $10.52M | $2.39M | 29.45% |
Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 9,831 | $422,899.59 | $457,288.96 | $34,389.37 | 8.13% |
Curtis Ellergodt Rothschild Investment LLC | 57,364 | $2.18M | $2.72M | $535,549.78 | 24.56% |
Tom McDonald Richards, MERRILL & PETERSON Inc. | 86,679 | $3.49M | $4.07M | $580,935.9 | 16.66% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 13.95M | $658.38M | $660.47M | $2.09M | 0.32% |
| ARCA Exchange | US Country |
The fund is a financial instrument that focuses on investing primarily in common stocks, aiming for capital growth by identifying companies with superior growth opportunities. It showcases a global investment perspective by allowing for up to 25% of its assets to be invested in stocks and securities of companies outside the United States. Investment decisions are made based on the professional judgment of its investment adviser, who adheres to a philosophy of investing in companies that are believed to be undervalued yet have promising long-term growth prospects. The fund is characterized as non-diversified, implying a focused approach to its investment strategy.
Invests in a wide array of common stocks, seeking to capitalize on the growth potential of various companies. This forms the core investment strategy of the fund, focusing on growth of capital through equity investments.
Up to 25% of the fund's portfolio may be allocated to common stocks and securities of companies domiciled outside the U.S. This diversification strategy aims to tap into international markets for potential growth opportunities beyond the domestic scope.
The fund’s investments are managed by professional advisers who utilize their judgment and expertise to select securities. Their approach is informed by a philosophy that seeks out companies they consider to be attractively valued and offering good, long-term investment prospects.
The fund maintains a non-diversified status, which means it may invest a larger portion of its assets in fewer securities. This approach allows for potentially higher returns from these concentrated investments but also poses a higher risk due to less diversification.